Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signalling in platelets

Author： Robson S.C.   Sévigny J.   Imai M.   Guckelberger O.   Enjyoji K.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.2, 2000-04, pp. : 155-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders

By  

Current Drug Targets, Vol. 1, Iss. 3, 2000-11 ,pp. : 285-296

Bentham Science Publishers

Access to resources Recommend Favorite

Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 5-20

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets in the rapidly expanding field of purinergic signalling

By Burnstock G  

Clinical Medicine, Vol. 2, Iss. 1, 2002-01 ,pp. : 45-53

Royal College Of Physicians

Access to resources Recommend Favorite

The therapeutic potential of CD39: interview with Dr Simon Robson

By Quigley Emma  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 649-652

Informa Healthcare

Access to resources Recommend Favorite

Thrombin signalling in platelets: the role of PARs

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite